0000899243-19-006445.txt : 20190306 0000899243-19-006445.hdr.sgml : 20190306 20190306163115 ACCESSION NUMBER: 0000899243-19-006445 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190228 FILED AS OF DATE: 20190306 DATE AS OF CHANGE: 20190306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nokes Rachael CENTRAL INDEX KEY: 0001769138 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38293 FILM NUMBER: 19662884 MAIL ADDRESS: STREET 1: C/O SCPHARMACEUITCALS, INC. STREET 2: 2400 DISTRICT AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: scPharmaceuticals Inc. CENTRAL INDEX KEY: 0001604950 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465184075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2400 DISTRICT AVENUE STREET 2: SUITE 310 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 617-517-0730 MAIL ADDRESS: STREET 1: 2400 DISTRICT AVENUE STREET 2: SUITE 310 CITY: BURLINGTON STATE: MA ZIP: 01803 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-02-28 0 0001604950 scPharmaceuticals Inc. SCPH 0001769138 Nokes Rachael C/O SCPHARMACEUTICALS INC. 2400 DISTRICT AVENUE, SUITE 310` BURLINGTON MA 01803 0 1 0 0 See Remarks Common Stock 13850 D Stock Option (Right to Buy) 1.66 2024-09-17 Common Stock 10455 D Stock Option (Right to Buy) 8.12 2025-03-13 Common Stock 10455 D Stock Option (Right to Buy) 3.81 2027-04-17 Common Stock 6426 D Stock Option (Right to Buy) 12.23 2028-01-17 Common Stock 17000 D Stock Option (Right to Buy) 4.88 2028-07-17 Common Stock 13850 D Consists of a restricted stock unit award made pursuant to the scPharmaceuticals Inc. 2017 Stock Option and Incentive Plan. The restricted stock units vest in equal annual installments over a two-year period beginning on February 25, 2019. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in no event later than two and one-half months after the end of the year in which such vesting date occurs. This option is fully vested. 25% of these shares vested on March 13, 2016 then in 36 equal monthly installments thereafter. 25% of these shares vested on April 17, 2018 then in 36 equal monthly installments thereafter. 25% of these shares vested on January 17, 2019 then in 36 equal monthly installments thereafter. 25% of these shares shall vest on July 17, 2019 then in 36 equal monthly installments thereafter. SVP, Finance; Principal Accounting Officer Exhibit 24 - Power of Attorney /s/ John Tucker, Attorney-in-Fact 2019-03-06 EX-24 2 attachment1.htm EX-24 DOCUMENT

                               Power of Attorney

      Know all by these presents that the undersigned hereby constitutes and
appoints each of John H. Tucker, Arthur McGivern and Courtney Hetrick, and with
full power of substitution, as the undersigned's true and lawful attorney-in-
fact to:

          (1) execute for and on behalf of the undersigned, in the undersigned's
          capacity as an officer of scPharmaceuticals Inc., a Delaware
          corporation (the "Company"), Forms 3, 4, and 5 in accordance with
          Section 16(a) of the Securities Exchange Act of 1934, as amended, and
          the rules thereunder;

          (2) do and perform any and all acts for and on behalf of the
          undersigned which may be necessary or desirable to complete and
          execute any such Form 3, 4, or 5, complete and execute any amendment
          or amendments thereto, and timely file such form with the SEC and any
          stock exchange or similar authority; and

          (3) take any other action of any type whatsoever in connection with
          the foregoing which, in the opinion of such attorney-in-fact, may be
          of benefit to, in the best interest of, or legally required by, the
          undersigned, it being understood that the documents executed by such
          attorney-in-fact on behalf of the undersigned pursuant to this Power
          of Attorney shall be in such form and shall contain such terms and
          conditions as such attorney-in-fact may approve in such attorney-in-
          fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934, as amended.

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 28th day of February, 2019.

/s/ Rachael Nokes
-----------------

Name: Rachael Nokes